March 1, 2017 / 9:21 PM / 6 months ago

BRIEF-Achaogen says Plazomicin NDA submission planned for second half of 2017

March 1 (Reuters) - Achaogen Inc

* Achaogen inc- plazomicin nda submission planned for second half of 2017

* Achaogen inc- plan to initiate clinical trial of orally-administered antibacterial candidate for esbl+ infections, c-scape, in 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below